TY - JOUR
T1 - A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States
T2 - A report from the CathPCI registry of the national cardiovascular data registry, 2010 through june 2011
AU - Dehmer, Gregory J.
AU - Weaver, Douglas
AU - Roe, Matthew T.
AU - Milford-Beland, Sarah
AU - Fitzgerald, Susan
AU - Hermann, Anthony
AU - Messenger, John
AU - Moussa, Issam
AU - Garratt, Kirk
AU - Rumsfeld, John
AU - Brindis, Ralph G.
N1 - Funding Information:
Dr. Dehmer has received honoraria/speaking fees from Sanofi-aventis, Daiichi-Sankyo, The Medicines Company, Boston Scientific, Medtronic, and Abbott Vascular; consultancies from The Medicines Company, Boston Scientific, and Abbott Vascular; equity holdings in Infarct Reduction Technologies (co-founder), Guided Delivery Systems, MedLogics, and Arstasis; and research support from Abbott Vascular (institutional PI) and Boston Scientific (national PI). Dr. Weaver is a member of the Data and Safety Monitoring Board of Boston Scientific. Dr. Roe is a consultant to AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company, GlaxoSmithKline, Merck & Co., Novartis Pharmaceutical Corporation, sanofi-aventis, and Schering-Plough Corporation; and has received research grants from Bristol-Myers Squibb , Eli Lilly & Company , sanofi-aventis , and Schering-Plough Corporation . Dr. Messenger has received an institutional research grant from Medtronic and Site PI . Dr. Garratt has received honoraria, and has investments. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2012/11/13
Y1 - 2012/11/13
N2 - Objectives: This study sought to provide a report to the public of data from the CathPCI Registry of the National Cardiovascular Data Registry. Background: The CathPCI Registry collects data from approximately 85% of the cardiac catheterization laboratories in the United States. Methods: Data were summarized for 6 consecutive calendar quarters beginning January 1, 2010, and ending June 30, 2011. This report includes 1,110,150 patients undergoing only diagnostic cardiac catheterization and 941,248 undergoing percutaneous coronary intervention (PCI). Results: Some notable findings include, for example, that on-site cardiac surgery was not available in 83% of facilities performing fewer than 200 PCIs annually, with these facilities representing 32.6% of the facilities reporting, but performing only 12.4% of the PCIs in this data sample. Patients 65 years of age or older represented 38.7% of those undergoing PCI, with 12.3% being 80 years of age or older. Almost 80% of PCI patients were overweight (body mass index <25 kg/m2), 80% had dyslipidemia, and 27.6% were current or recent smokers. Among patients undergoing elective PCI, 52% underwent a stress study before the procedure, with stress myocardial perfusion being used most frequently. Calcium scores and coronary computed tomography angiography were used very infrequently (<3%) before diagnostic or PCI procedures. Radial artery access was used in 8.3% of diagnostic and 6.9% of PCI procedures. Primary PCI was performed with a median door-to-balloon time of 64.5 min for nontransfer patients and 121 min for transfer patients. In-hospital risk-adjusted mortality in ST-segment elevation myocardial infarction patients was 5.2% in this sample. Conclusions: Data from the CathPCI Registry provide a contemporary view of the current practice of invasive cardiology in the United States.
AB - Objectives: This study sought to provide a report to the public of data from the CathPCI Registry of the National Cardiovascular Data Registry. Background: The CathPCI Registry collects data from approximately 85% of the cardiac catheterization laboratories in the United States. Methods: Data were summarized for 6 consecutive calendar quarters beginning January 1, 2010, and ending June 30, 2011. This report includes 1,110,150 patients undergoing only diagnostic cardiac catheterization and 941,248 undergoing percutaneous coronary intervention (PCI). Results: Some notable findings include, for example, that on-site cardiac surgery was not available in 83% of facilities performing fewer than 200 PCIs annually, with these facilities representing 32.6% of the facilities reporting, but performing only 12.4% of the PCIs in this data sample. Patients 65 years of age or older represented 38.7% of those undergoing PCI, with 12.3% being 80 years of age or older. Almost 80% of PCI patients were overweight (body mass index <25 kg/m2), 80% had dyslipidemia, and 27.6% were current or recent smokers. Among patients undergoing elective PCI, 52% underwent a stress study before the procedure, with stress myocardial perfusion being used most frequently. Calcium scores and coronary computed tomography angiography were used very infrequently (<3%) before diagnostic or PCI procedures. Radial artery access was used in 8.3% of diagnostic and 6.9% of PCI procedures. Primary PCI was performed with a median door-to-balloon time of 64.5 min for nontransfer patients and 121 min for transfer patients. In-hospital risk-adjusted mortality in ST-segment elevation myocardial infarction patients was 5.2% in this sample. Conclusions: Data from the CathPCI Registry provide a contemporary view of the current practice of invasive cardiology in the United States.
KW - cardiac catheterization
KW - invasive cardiology
KW - National Cardiovascular Data Registry
KW - percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=84868563479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868563479&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2012.08.966
DO - 10.1016/j.jacc.2012.08.966
M3 - Article
C2 - 23083784
AN - SCOPUS:84868563479
SN - 0735-1097
VL - 60
SP - 2017
EP - 2031
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 20
ER -